Covered recipient · General Payments record
MARY THERESA CARDONE
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2021
$1,863.62
- Reported across 177 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $352.75 | 27 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $166.39 | 14 |
| Novo Nordisk AS | $41.86 | 3 |
| Lilly USA, LLC | $28.68 | 2 |
| Amgen Inc. | $25.45 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $25.34 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.28 | 1 |
| Amarin Pharma Inc. | $17.82 | 1 |
| SI-BONE, INC. | $14.99 | 1 |
| Merck Sharp & Dohme Corporation | $11.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2021 201820192020
Record-level detail is published for PY2021; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $9.76 | 01/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794212867 | CMS |
| AbbVie Inc. | $12.20 | 01/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794212869 | CMS |
| AbbVie Inc. | $2.07 | 01/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794212871 | CMS |
| AbbVie Inc. | $1.87 | 01/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794212873 | CMS |
| AbbVie Inc. | $14.59 | 01/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794212875 | CMS |
| AbbVie Inc. | $7.53 | 02/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794212877 | CMS |
| AbbVie Inc. | $15.77 | 04/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794212879 | CMS |
| AbbVie Inc. | $9.55 | 04/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794212881 | CMS |
| AbbVie Inc. | $22.21 | 04/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794212883 | CMS |
| AbbVie Inc. | $12.98 | 04/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794212885 | CMS |
| AbbVie Inc. | $10.61 | 05/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794212887 | CMS |
| AbbVie Inc. | $20.51 | 05/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794212889 | CMS |
| AbbVie Inc. | $13.86 | 05/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794212891 | CMS |
| AbbVie Inc. | $12.88 | 05/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794212893 | CMS |
| Amarin Pharma Inc. | $17.82 | 02/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 815054147 | CMS |
| Amgen Inc. | $12.18 | 04/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825595733 | CMS |
| Amgen Inc. | $13.27 | 06/21/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825595729 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.28 | 05/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 763464910 | CMS |
| Lilly USA, LLC | $15.80 | 03/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818656205 | CMS |
| Lilly USA, LLC | $12.88 | 04/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818609905 | CMS |
| Merck Sharp & Dohme Corporation | $11.94 | 05/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 848622315 | CMS |
| Novartis Pharmaceuticals Corporation | $12.57 | 02/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 812626977 | CMS |
| Novartis Pharmaceuticals Corporation | $12.77 | 03/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 812626979 | CMS |
| Novo Nordisk Inc | $11.17 | 04/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811578023 | CMS |
| Novo Nordisk Inc | $12.32 | 05/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 810925863 | CMS |
| Novo Nordisk Inc | $18.37 | 06/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811287349 | CMS |
| SI-BONE, INC. | $14.99 | 03/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 845531425 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.